Show simple item record

dc.contributor.authorPan, Y
dc.contributor.authorLu, J
dc.contributor.authorFeng, X
dc.contributor.authorLu, S
dc.contributor.authorYang, Y
dc.contributor.authorYang, G
dc.contributor.authorTan, S
dc.contributor.authorWang, L
dc.contributor.authorLi, P
dc.contributor.authorLuo, S
dc.contributor.authorLu, B
dc.date.accessioned2023-11-02T13:13:37Z
dc.date.available2023-11-02T13:13:37Z
dc.date.issued2023-11
dc.identifier.issn1552-4450
dc.identifier.issn1552-4469
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/21551
dc.description.abstract

RNA molecules with the expanded CAG repeat (eCAGr) may undergo sol–gel phase transitions, but the functional impact of RNA gelation is completely unknown. Here, we demonstrate that the eCAGr RNA may form cytoplasmic gel-like foci that are rapidly degraded by lysosomes. These RNA foci may significantly reduce the global protein synthesis rate, possibly by sequestering the translation elongation factor eEF2. Disrupting the eCAGr RNA gelation restored the global protein synthesis rate, whereas enhanced gelation exacerbated this phenotype. eEF2 puncta were significantly enhanced in brain slices from a knock-in mouse model and from patients with Huntington’s disease, which is a CAG expansion disorder expressing eCAGr RNA. Finally, neuronal expression of the eCAGr RNA by adeno-associated virus injection caused significant behavioral deficits in mice. Our study demonstrates the existence of RNA gelation inside the cells and reveals its functional impact, providing insights into repeat expansion diseases and functional impacts of RNA phase transition.

dc.format.extent1372-1383
dc.format.mediumPrint-Electronic
dc.languageen
dc.publisherSpringer Science and Business Media LLC
dc.subjectHumans
dc.subjectMice
dc.subjectAnimals
dc.subjectTrinucleotide Repeat Expansion
dc.subjectRNA
dc.subjectProtein Biosynthesis
dc.subjectHuntington Disease
dc.subjectDisease Models, Animal
dc.subjectHuntingtin Protein
dc.titleGelation of cytoplasmic expanded CAG RNA repeats suppresses global protein synthesis
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/37592155
plymouth.issue11
plymouth.volume19
plymouth.publisher-urlhttp://dx.doi.org/10.1038/s41589-023-01384-5
plymouth.publication-statusPublished
plymouth.journalNature Chemical Biology
dc.identifier.doi10.1038/s41589-023-01384-5
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group|Plymouth|Research Groups|Institute of Translational and Stratified Medicine (ITSMED)|CBR
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA01 Clinical Medicine
plymouth.organisational-group|Plymouth|Faculty of Health|Peninsula Medical School
plymouth.organisational-group|Plymouth|Users by role|Researchers in ResearchFish submission
dc.publisher.placeUnited States
dcterms.dateAccepted2023-06-13
dc.date.updated2023-11-02T13:13:07Z
dc.rights.embargodate2024-2-16
dc.identifier.eissn1552-4469
rioxxterms.versionofrecord10.1038/s41589-023-01384-5


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV